Tea health claims mean hot water with FDA
September 9, 2010
The Food and Drug Administration has issued warning letters to two leading beverage manufacturers over health claims related to green tea. A letter to Dr Pepper Snapple Group said that the label for Canada Dry Sparkling Green Tea Ginger Ale improperly included the word “enhanced” to describe antioxidant benefits from green tea. A letter to Unilever took issue with citations on its Lipton website for studies about green tea lowering cholesterol, which could give it the status of a drug. Both companies said they are reviewing the situations and are committed to full compliance with the law.